Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- OncoTree
- BREAST
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07259226 | Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers(OASIS) | recruiting | Phase 2 | 400 | UNICANCEROTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT06781996 | A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer(HOPE) | recruiting | Phase 3 | 180 | Gustave Roussy, Cancer Campus, Grand ParisOTHER |
| 1 |
| Dec 1, 2025 |
| clinicaltrials |
| NCT07159451 | A Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast Cancer(POP-ELA) | recruiting | Phase 2 | 140 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Dec 1, 2025 | clinicaltrials |
| NCT04874064 | TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence(TRICIA) | recruiting | — | 130 | Jewish General HospitalOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT06762496 | A New Tool to Promote Patient's Engagement in Their Healthcare Process | recruiting | — | 180 | European Institute of OncologyOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT05982678 | Basket Study for Oligo-metastatic Breast Cancer(ANISE) | recruiting | Phase 2 | 72 | The Netherlands Cancer InstituteOTHER | 1 | Nov 26, 2025 | clinicaltrials |
| NCT06107686 | A Study of YL202 in Selected Patients With Advanced Solid Tumors | recruiting | Phase 2 | 200 | MediLink Therapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Nov 26, 2025 | clinicaltrials |
| NCT06146231 | Motiva Flora® Aesthetic Breast Recon® Clinical Study | recruiting | N/A | 66 | Establishment LabsINDUSTRY | 4 | Nov 26, 2025 | clinicaltrials |
| NCT06273800 | Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients(Chemosense) | recruiting | N/A | 100 | The Netherlands Cancer InstituteOTHER | 1 | Nov 26, 2025 | clinicaltrials |
| NCT07044583 | SAVE Trial: SAfe Opioid Use Video Education(SAVE) | recruiting | N/A | 68 | University of UtahOTHER | 1 | Nov 26, 2025 | clinicaltrials |
| NCT07250386 | A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors(PBC102) | recruiting | Phase 1 | 48 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Nov 26, 2025 | clinicaltrials |
| NCT07251868 | Evaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study | recruiting | — | 100 | Peking University Cancer Hospital & InstituteOTHER | 1 | Nov 26, 2025 | clinicaltrials |
| NCT06817226 | BREAST Choice Decision Tool R21 - AIM2(BREASTChoice) | recruiting | N/A | 50 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT06072807 | Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer | recruiting | Phase 4 | 20 | Weill Medical College of Cornell UniversityOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT06833255 | A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York | recruiting | N/A | 125 | Roswell Park Cancer InstituteOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT06864754 | WashU DIEP Flap Video and Patient Understanding Improvement | recruiting | N/A | 300 | Washington University School of MedicineOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07128030 | Moderate-Intensity Exercise and Pain Sensitization in Breast Cancer Survivors: A Case-Based Study | recruiting | N/A | 10 | Universidad Rey Juan CarlosOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07178171 | A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC | recruiting | Phase 1 | 30 | Xijing HospitalOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07245069 | Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients(Alpaca) | recruiting | Phase 2 | 100 | University Medical Centre LjubljanaOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT05146778 | A Study to Reduce Persistent Post-mastectomy Pain Using Opioid-free Anesthesia(RELIEF) | recruiting | N/A | 230 | Gangnam Severance HospitalOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT06185205 | ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy(ASHBY) | recruiting | Phase 2 | 170 | Virginia Commonwealth UniversityOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT06322888 | Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D) | recruiting | N/A | 46 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT07029490 | Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study(EMPOWER) | recruiting | N/A | 2,700 | University of UtahOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT05530057 | Eribulin With or Without Trastuzumab-biosimilar in Patients With HER2-overexpressed Recurrent or Stage IV Breast Cancer(ESPERO) | recruiting | Phase 2 | 180 | Seoul National University HospitalOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT05900895 | Estradiol Plus Olaparib for Breast Cancer (PHOEBE)(PHOEBE) | recruiting | Phase 1 | 6 | Mary D ChamberlinOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT06535893 | Sustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast Cancer | recruiting | Phase 2 | 100 | Nagoya City UniversityOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT06830382 | HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBC | recruiting | — | 70 | Renske AltenaOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT07180056 | Adjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast Cancer | recruiting | — | 229 | Wenjin YinOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT07233499 | Evaluation of the Cardioprotective Effect of Nebivolol on Trastuzumab-Induced Cardiotoxicity in Breast Cancer Patients | recruiting | Phase 2 | 56 | Ain Shams UniversityOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT04543799 | Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer(SIESTA) | recruiting | — | 60 | Oncology Institute of Southern SwitzerlandOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06347926 | Study of Sexual Quality of Life in Women With Breast Cancer Who Had Multidisciplinary Management With Photobiomodulation for Genitourinary Syndrome of the Menopause(EVABIOSEIN) | recruiting | N/A | 25 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06364267 | Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer.(BabyTears) | recruiting | Phase 2 | 140 | Andrea DeCensiOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06795529 | Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer(TARGET-PC) | recruiting | N/A | 400 | Massachusetts General HospitalOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07130383 | A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors | recruiting | Phase 2 | 210 | Minghui Pharmaceutical (Hangzhou) LtdINDUSTRY | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07180082 | Continuous or Intermittent Pyrotinib for HER2-positive Advanced Breast Cancer(CORIN-PYRA) | recruiting | Phase 2 | 186 | Wenjin YinOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07180160 | Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer(ITHRAN) | recruiting | Phase 2 | 123 | Wenjin YinOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07180264 | Trastuzumab Deruxtecan in Advanced Breast Cancer | recruiting | — | 118 | Wenjin YinOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT05973864 | Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery(CAPPA) | recruiting | Phase 2 | 220 | UNICANCEROTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT06398067 | Stress Management Intervention Among Breast and Gynecologic Cancer Patients in Viet Nam | recruiting | N/A | 285 | Boston UniversityOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT07231159 | Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots | recruiting | — | 200 | AdventHealthOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT05559164 | Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted | recruiting | Phase 2 | 60 | Rutgers, The State University of New JerseyOTHER | 1 | Nov 14, 2025 | clinicaltrials |
| NCT06139107 | RADIANT: Pre-op Radiation With Abemaciclib and Letrozole | recruiting | Phase 1 | 15 | Mridula George, MDOTHER | 1 | Nov 14, 2025 | clinicaltrials |
| NCT04526587 | Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors | recruiting | — | 700 | Roswell Park Cancer InstituteOTHER | 1 | Nov 13, 2025 | clinicaltrials |
| NCT06867484 | Breast Re-irradiation After Second Ipsilateral Lumpectomy(BRASIL) | recruiting | N/A | 114 | Youssef ZeidanOTHER | 1 | Nov 13, 2025 | clinicaltrials |
| NCT03694756 | TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer(TMEM-MRI) | recruiting | N/A | 95 | Montefiore Medical CenterOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT04553770 | Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer | recruiting | Phase 2 | 88 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT05978128 | Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants | recruiting | N/A | 800 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT06008275 | Neratinib in Combination With Ruxolitinib in Patients With mTNBC | recruiting | Early Phase 1 | 20 | Baylor Research InstituteOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT06144164 | A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer | recruiting | Phase 3 | 285 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT05929768 | Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer | recruiting | Phase 3 | 2,400 | SWOG Cancer Research NetworkNETWORK | 3 | Nov 5, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Dec 2, 2025source: clinicaltrials